The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PATRIOT Trial: Randomized phase II study of prostate stereotactic body radiotherapy comparing 11 versus 29 days overall treatment time.
 
Harvey Charles Quon
Consulting or Advisory Role - Amgen
 
Aldrich Ong
No Relationships to Disclose
 
Patrick Cheung
No Relationships to Disclose
 
William Chu
No Relationships to Disclose
 
Hans T. Chung
No Relationships to Disclose
 
Danny Vesprini
No Relationships to Disclose
 
Amit Chowdhury
No Relationships to Disclose
 
Dilip Panjwani
No Relationships to Disclose
 
Geordi Pang
No Relationships to Disclose
 
Renee Korol
No Relationships to Disclose
 
Melanie Davidson
No Relationships to Disclose
 
Ananth Ravi
No Relationships to Disclose
 
Boyd McCurdy
No Relationships to Disclose
 
Liying Zhang
No Relationships to Disclose
 
Oliver Bucher
No Relationships to Disclose
 
Alexandre Mamedov
No Relationships to Disclose
 
Andrea Deabreu
No Relationships to Disclose
 
Elizabeth Lylyk
No Relationships to Disclose
 
D. Andrew Loblaw
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb (I); Elekta; GlaxoSmithKline (I); Janssen Oncology; Merck (I); Novartis (I); Paladin; Roche (I); Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bristol-Myers Squibb (I); GlaxoSmithKline (I); Janssen Oncology; Merck (I); Novartis (I); Roche (I); Sanofi
Research Funding - Paladin (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Janssen Oncology; Paladin